BackInspire Medical Systems Overview

Inspire Medical Systems EBIT

Inspire Medical Systems's EBIT is $49M, below the Healthcare sector average of $110B.

Get informed when a big investor buys or sells

+ Follow

Quarterly EBIT

-$514.00K
↑ 77.92% YoY

As of Jun 30, 2026

Annual EBIT (TTM)

$49.22M
↓ 21.79% YoY

Trailing 12 months ending Jun 30, 2026

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

Inspire Medical Systems (INSP) FAQ

Inspire Medical Systems's ebit stands at $49M as of June 2026. That compares with $63M in the prior-year period — down 21.8% year over year. That is below the Healthcare sector average of $110B. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

Inspire Medical Systems reported $49M in EBIT versus $63M a year earlier — a 21.8% year-over-year decrease. The historical chart on this page makes it easier to see whether that move is part of a longer pattern.

Inspire Medical Systems sits lower the Healthcare benchmark ($110B) with a EBIT of $49M. That is roughly 100.0% below the sector mean. Peer context matters because what looks expensive or cheap in absolute terms can be normal for the sector.

That compares with $63M in the prior-year period — down 21.8% year over year. Sustained growth in EBIT can support a stronger franchise, while sharp declines may reflect divestitures, weaker demand, or accounting changes. Always read YoY moves with the footnotes of recent filings in mind.

The history chart shows how Inspire Medical Systems's EBIT evolved across reporting periods, while the comparison chart places INSP next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.